DOI: 10.1093/hmg/ddn419. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse

17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse

10.1093/hmg/ddn419

Crossref journal-article

Oxford University Press (OUP)

Human Molecular Genetics (286)

Bibliography

Tokui, K., Adachi, H., Waza, M., Katsuno, M., Minamiyama, M., Doi, H., Tanaka, K., Hamazaki, J., Murata, S., Tanaka, F., & Sobue, G. (2008). 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Human Molecular Genetics, 18(5), 898â910.

Authors 11

Keisuke Tokui (first)
Hiroaki Adachi (additional)
Masahiro Waza (additional)
Masahisa Katsuno (additional)
Makoto Minamiyama (additional)
Hideki Doi (additional)
Keiji Tanaka (additional)
Jun Hamazaki (additional)
Shigeo Murata (additional)
Fumiaki Tanaka (additional)
Gen Sobue (additional)

References 71 Referenced 92

10.1038/nrg1690 / Nat. Rev. Genet. / Therapeutics development for triplet repeat expansion diseases by Di Prospero (2005)
10.1111/j.1365-2990.2007.00830.x / Neuropathol. Appl. Neurobiol. / Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy by Adachi (2007)
10.1093/hmg/5.9.1253 / Hum. Mol. Genet. / Founder effect in spinal and bulbar muscular atrophy (SBMA) by Tanaka (1996)
{'issue': 'Pt 1', 'key': 'key\n\t\t\t\t20170522132258_DDN419C4', 'first-page': '209', 'article-title': 'X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain', 'volume': '112', 'author': 'Sobue', 'year': '1989'} / X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain by Sobue (1989)
10.1093/brain/awh381 / Brain / Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients by Adachi (2005)
10.1177/153537020322800201 / Exp. Biol. Med. (Maywood) / Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery by Pratt (2003)
10.1016/j.yfrne.2004.03.001 / Front. Neuroendocrinol. / The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons by Poletti (2004)
{'key': 'key\n\t\t\t\t20170522132258_DDN419C8', 'first-page': '962', 'article-title': 'Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer', 'volume': '8', 'author': 'Neckers', 'year': '2002', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. / Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer by Neckers (2002)
10.1038/nrn1587 / Nat. Rev. Neurosci. / Modulation of neurodegeneration by molecular chaperones by Muchowski (2005)
10.1196/annals.1391.012 / Ann. N. Y. Acad. Sci. / Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress by Workman (2007)
10.1038/nm1298 / Nat. Med. / 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration by Waza (2005)
10.1007/s00280-004-0947-2 / Cancer Chemother. Pharmacol. / Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models by Smith (2005)
10.1159/000101849 / Neurodegener. Dis. / Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy by Herbst (2007)
10.1007/s00280-001-0380-8 / Cancer Chemother. Pharmacol. / Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats by Egorin (2002)
10.1038/nm1005-1052 / Nat. Med. / Targeting toxic proteins for turnover by La Spada (2005)
10.1038/502 / Nat. Genet. / Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 by Cummings (1998)
10.1016/S0896-6273(03)00606-8 / Neuron / The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg by Ciechanover (2003)
10.1126/science.292.5521.1552 / Science / Impairment of the ubiquitin-proteasome system by protein aggregation by Bence (2001)
10.1093/hmg/10.10.1049 / Hum. Mol. Genet. / Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release by Jana (2001)
10.1016/j.molcel.2004.12.021 / Mol. Cell / Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation by Bennett (2005)
10.1038/nature06022 / Nature / Global changes to the ubiquitin system in Huntington’s disease by Bennett (2007)
10.1016/j.neurobiolaging.2006.05.015 / Neurobiol. Aging / Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy by Rusmini (2007)
10.1083/jcb.200709080 / J. Cell Biol. / Impaired ubiquitin-proteasome system activity in the synapses of Huntington’s disease mice by Wang (2008)
10.1002/ana.20207 / Ann. Neurol. / Generalized brain and skin proteasome inhibition in Huntington’s disease by Seo (2004)
10.1093/hmg/ddi064 / Hum. Mol. Genet. / Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation by Bowman (2005)
10.1093/hmg/ddi423 / Hum. Mol. Genet. / Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington’s disease mice: exclusion of proteasome activator REGgamma as a therapeutic target by Bett (2006)
10.1083/jcb.200306038 / J. Cell Biol. / Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity by Zhou (2003)
10.1074/jbc.M107706200 / J. Biol. Chem. / Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival by Ding (2002)
10.1523/JNEUROSCI.23-37-11653.2003 / J. Neurosci. / Neuronal induction of the immunoproteasome in Huntington’s disease by Diaz-Hernandez (2003)
10.1016/S0896-6273(02)00834-6 / Neuron / Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy by Katsuno (2002)
10.1038/nbt851 / Nat. Biotechnol. / A transgenic mouse model of the ubiquitin/proteasome system by Lindsten (2003)
10.1038/75406 / Nat. Biotechnol. / Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells by Dantuma (2000)
{'key': 'key\n\t\t\t\t20170522132258_DDN419C33', 'first-page': '705', 'article-title': 'Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells', 'volume': '10', 'author': 'Whitesell', 'year': '1996', 'journal-title': 'Mol. Endocrinol.'} / Mol. Endocrinol. / Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells by Whitesell (1996)
10.1074/jbc.271.37.22796 / J. Biol. Chem. / Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin by Mimnaugh (1996)
10.1158/0008-5472.CAN-03-3531 / Cancer Res. / Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein by Bonvini (2004)
10.1523/JNEUROSCI.23-06-02203.2003 / J. Neurosci. / Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein by Adachi (2003)
10.1016/j.tins.2007.08.005 / Trends Neurosci. / The ubiquitin-proteasome pathway in health and disease of the nervous system by Hegde (2007)
10.1073/pnas.97.6.2898 / Proc. Natl Acad. Sci. USA / Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington’s disease by Wyttenbach (2000)
10.1016/S0092-8674(00)80513-9 / Cell / Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation by Davies (1997)
10.1126/science.277.5334.1990 / Science / Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain by DiFiglia (1997)
10.1016/S0092-8674(00)80623-6 / Cell / Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease by Yamamoto (2000)
10.1523/JNEUROSCI.2978-04.2004 / J. Neurosci. / Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice by Zu (2004)
10.1038/77046 / Nat. Genet. / Gene-expression profile of the ageing brain in mice by Lee (2000)
10.1016/S0306-4522(00)00067-1 / Neuroscience / Decreased levels of proteasome activity and proteasome expression in aging spinal cord by Keller (2000)
10.1038/nature01913 / Nature / A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors by Kamal (2003)
10.1007/s002800000242 / Cancer Chemother. Pharmacol. / Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1 by Egorin (2001)
{'key': 'key\n\t\t\t\t20170522132258_DDN419C47', 'first-page': '308', 'article-title': 'Comparison of geldanamycin (NSC-122750) and 17-allylaminogeldanamycin (NSC-330507D) toxicity in rats', 'volume': '38', 'author': 'Page', 'year': '1997', 'journal-title': 'Proc. Am. Assoc. Cancer Res.'} / Proc. Am. Assoc. Cancer Res. / Comparison of geldanamycin (NSC-122750) and 17-allylaminogeldanamycin (NSC-330507D) toxicity in rats by Page (1997)
10.1007/BF00689048 / Cancer Chemother. Pharmacol. / Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent by Supko (1995)
10.1158/1078-0432.CCR-06-2468 / Clin. Cancer Res. / Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity—pharmacodynamic drug-drug interaction modeling by Wetzler (2007)
10.1007/s00280-004-0939-2 / Cancer Chemother. Pharmacol. / In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative by Hollingshead (2005)
10.3816/CLM.2006.n.034 / Clin. Lymphoma Myeloma / 17-dimethylaminoethylamino-17-demethoxygeldanamycin in patients with advanced-stage solid tumors and lymphoma: a phase I study by Shadad (2006)
10.1002/pbc.21508 / Pediatr. Blood Cancer / Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program by Smith (2008)
{'key': 'key\n\t\t\t\t20170522132258_DDN419C53', 'first-page': '2385', 'article-title': 'Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations', 'volume': '58', 'author': 'Egorin', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations by Egorin (1998)
10.1007/s00109-007-0251-9 / J. Mol. Med. / Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response by Zhang (2007)
10.1093/hmg/10.12.1307 / Hum. Mol. Genet. / Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington’s disease by Sittler (2001)
10.1073/pnas.0506249102 / Proc. Natl Acad. Sci. USA / Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease by Katsuno (2005)
10.1093/hmg/11.5.515 / Hum. Mol. Genet. / Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy by Bailey (2002)
10.1074/jbc.M601603200 / J. Biol. Chem. / CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation by Al-Ramahi (2006)
10.1523/JNEUROSCI.1242-07.2007 / J. Neurosci. / CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by Adachi (2007)
10.1172/JCI29715 / J. Clin. Invest. / The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins by Dickey (2007)
10.1038/nm1102-1185 / Nat. Med. / Pharmacological prevention of Parkinson disease in Drosophila by Auluck (2002)
10.1046/j.1471-4159.2002.00835.x / J. Neurochem. / Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia by Lu (2002)
10.1002/jnr.10139 / J. Neurosci. Res. / Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis by Murphy (2002)
10.1038/nm878 / Nat. Med. / Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy by Katsuno (2003)
10.1038/sj.emboj.7601338 / EMBO J. / A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes by Hamazaki (2006)
10.1093/embo-reports/kve246 / EMBO Rep. / CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein by Murata (2001)
10.1093/hmg/ddh131 / Hum. Mol. Genet. / Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy by Minamiyama (2004)
10.1093/hmg/10.10.1039 / Hum. Mol. Genet. / Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death by Adachi (2001)
10.1016/j.molcel.2006.11.015 / Mol. Cell / Cooperation of multiple chaperones required for the assembly of mammalian 20S proteasomes by Hirano (2006)
10.1128/MCB.00509-07 / Mol. Cell. Biol. / Rpn10-mediated degradation of ubiquitinated proteins is essential for mouse development by Hamazaki (2007)
10.1016/S0076-6879(05)99034-4 / Methods Enzymol. / Monitoring of ubiquitin-dependent proteolysis with green fluorescent protein substrates by Menendez-Benito (2005)

Dates

Type	When
Created	16 years, 8 months ago (Dec. 9, 2008, 3:45 p.m.)
Deposited	6 years, 3 months ago (May 15, 2019, 7:41 p.m.)
Indexed	1 year ago (Aug. 9, 2024, 8:57 p.m.)
Issued	16 years, 8 months ago (Dec. 9, 2008)
Published	16 years, 8 months ago (Dec. 9, 2008)
Published Online	16 years, 8 months ago (Dec. 9, 2008)
Published Print	16 years, 6 months ago (March 1, 2009)

Funders 0

None

BibTeX

@article{Tokui_2008, title={17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse}, volume={18}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddn419}, DOI={10.1093/hmg/ddn419}, number={5}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Tokui, Keisuke and Adachi, Hiroaki and Waza, Masahiro and Katsuno, Masahisa and Minamiyama, Makoto and Doi, Hideki and Tanaka, Keiji and Hamazaki, Jun and Murata, Shigeo and Tanaka, Fumiaki and Sobue, Gen}, year={2008}, month=dec, pages={898–910} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        8,
        10
      ]
    ],
    "date-time": "2024-08-10T00:57:41Z",
    "timestamp": 1723251461816
  },
  "reference-count": 71,
  "publisher": "Oxford University Press (OUP)",
  "issue": "5",
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2009,
        3,
        1
      ]
    ]
  },
  "DOI": "10.1093/hmg/ddn419",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2008,
        12,
        9
      ]
    ],
    "date-time": "2008-12-09T20:45:39Z",
    "timestamp": 1228855539000
  },
  "page": "898-910",
  "source": "Crossref",
  "is-referenced-by-count": 92,
  "title": "17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse",
  "prefix": "10.1093",
  "volume": "18",
  "author": [
    {
      "given": "Keisuke",
      "family": "Tokui",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Hiroaki",
      "family": "Adachi",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Masahiro",
      "family": "Waza",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Masahisa",
      "family": "Katsuno",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Makoto",
      "family": "Minamiyama",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Hideki",
      "family": "Doi",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Keiji",
      "family": "Tanaka",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Jun",
      "family": "Hamazaki",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Shigeo",
      "family": "Murata",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Fumiaki",
      "family": "Tanaka",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Gen",
      "family": "Sobue",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "286",
  "published-online": {
    "date-parts": [
      [
        2008,
        12,
        9
      ]
    ]
  },
  "reference": [
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C1",
      "doi-asserted-by": "crossref",
      "first-page": "756",
      "DOI": "10.1038/nrg1690",
      "article-title": "Therapeutics development for triplet repeat expansion diseases",
      "volume": "6",
      "author": "Di Prospero",
      "year": "2005",
      "journal-title": "Nat. Rev. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C2",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "DOI": "10.1111/j.1365-2990.2007.00830.x",
      "article-title": "Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy",
      "volume": "33",
      "author": "Adachi",
      "year": "2007",
      "journal-title": "Neuropathol. Appl. Neurobiol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C3",
      "doi-asserted-by": "crossref",
      "first-page": "1253",
      "DOI": "10.1093/hmg/5.9.1253",
      "article-title": "Founder effect in spinal and bulbar muscular atrophy (SBMA)",
      "volume": "5",
      "author": "Tanaka",
      "year": "1996",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "issue": "Pt 1",
      "key": "key\n\t\t\t\t20170522132258_DDN419C4",
      "first-page": "209",
      "article-title": "X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain",
      "volume": "112",
      "author": "Sobue",
      "year": "1989"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C5",
      "doi-asserted-by": "crossref",
      "first-page": "659",
      "DOI": "10.1093/brain/awh381",
      "article-title": "Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients",
      "volume": "128",
      "author": "Adachi",
      "year": "2005",
      "journal-title": "Brain"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C6",
      "doi-asserted-by": "crossref",
      "first-page": "111",
      "DOI": "10.1177/153537020322800201",
      "article-title": "Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery",
      "volume": "228",
      "author": "Pratt",
      "year": "2003",
      "journal-title": "Exp. Biol. Med. (Maywood)"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C7",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/j.yfrne.2004.03.001",
      "article-title": "The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons",
      "volume": "25",
      "author": "Poletti",
      "year": "2004",
      "journal-title": "Front. Neuroendocrinol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C8",
      "first-page": "962",
      "article-title": "Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer",
      "volume": "8",
      "author": "Neckers",
      "year": "2002",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C9",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "DOI": "10.1038/nrn1587",
      "article-title": "Modulation of neurodegeneration by molecular chaperones",
      "volume": "6",
      "author": "Muchowski",
      "year": "2005",
      "journal-title": "Nat. Rev. Neurosci."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C10",
      "doi-asserted-by": "crossref",
      "first-page": "202",
      "DOI": "10.1196/annals.1391.012",
      "article-title": "Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress",
      "volume": "1113",
      "author": "Workman",
      "year": "2007",
      "journal-title": "Ann. N. Y. Acad. Sci."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C11",
      "doi-asserted-by": "crossref",
      "first-page": "1088",
      "DOI": "10.1038/nm1298",
      "article-title": "17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration",
      "volume": "11",
      "author": "Waza",
      "year": "2005",
      "journal-title": "Nat. Med."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C12",
      "doi-asserted-by": "crossref",
      "first-page": "126",
      "DOI": "10.1007/s00280-004-0947-2",
      "article-title": "Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models",
      "volume": "56",
      "author": "Smith",
      "year": "2005",
      "journal-title": "Cancer Chemother. Pharmacol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C13",
      "doi-asserted-by": "crossref",
      "first-page": "254",
      "DOI": "10.1159/000101849",
      "article-title": "Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy",
      "volume": "4",
      "author": "Herbst",
      "year": "2007",
      "journal-title": "Neurodegener. Dis."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C14",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "DOI": "10.1007/s00280-001-0380-8",
      "article-title": "Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats",
      "volume": "49",
      "author": "Egorin",
      "year": "2002",
      "journal-title": "Cancer Chemother. Pharmacol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C15",
      "doi-asserted-by": "crossref",
      "first-page": "1052",
      "DOI": "10.1038/nm1005-1052",
      "article-title": "Targeting toxic proteins for turnover",
      "volume": "11",
      "author": "La Spada",
      "year": "2005",
      "journal-title": "Nat. Med."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C16",
      "doi-asserted-by": "crossref",
      "first-page": "148",
      "DOI": "10.1038/502",
      "article-title": "Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1",
      "volume": "19",
      "author": "Cummings",
      "year": "1998",
      "journal-title": "Nat. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C17",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "DOI": "10.1016/S0896-6273(03)00606-8",
      "article-title": "The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg",
      "volume": "40",
      "author": "Ciechanover",
      "year": "2003",
      "journal-title": "Neuron"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C18",
      "doi-asserted-by": "crossref",
      "first-page": "1552",
      "DOI": "10.1126/science.292.5521.1552",
      "article-title": "Impairment of the ubiquitin-proteasome system by protein aggregation",
      "volume": "292",
      "author": "Bence",
      "year": "2001",
      "journal-title": "Science"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C19",
      "doi-asserted-by": "crossref",
      "first-page": "1049",
      "DOI": "10.1093/hmg/10.10.1049",
      "article-title": "Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release",
      "volume": "10",
      "author": "Jana",
      "year": "2001",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C20",
      "doi-asserted-by": "crossref",
      "first-page": "351",
      "DOI": "10.1016/j.molcel.2004.12.021",
      "article-title": "Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation",
      "volume": "17",
      "author": "Bennett",
      "year": "2005",
      "journal-title": "Mol. Cell"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C21",
      "doi-asserted-by": "crossref",
      "first-page": "704",
      "DOI": "10.1038/nature06022",
      "article-title": "Global changes to the ubiquitin system in Huntington\u2019s disease",
      "volume": "448",
      "author": "Bennett",
      "year": "2007",
      "journal-title": "Nature"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C22",
      "doi-asserted-by": "crossref",
      "first-page": "1099",
      "DOI": "10.1016/j.neurobiolaging.2006.05.015",
      "article-title": "Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy",
      "volume": "28",
      "author": "Rusmini",
      "year": "2007",
      "journal-title": "Neurobiol. Aging"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C23",
      "doi-asserted-by": "crossref",
      "first-page": "1177",
      "DOI": "10.1083/jcb.200709080",
      "article-title": "Impaired ubiquitin-proteasome system activity in the synapses of Huntington\u2019s disease mice",
      "volume": "180",
      "author": "Wang",
      "year": "2008",
      "journal-title": "J. Cell Biol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C24",
      "doi-asserted-by": "crossref",
      "first-page": "319",
      "DOI": "10.1002/ana.20207",
      "article-title": "Generalized brain and skin proteasome inhibition in Huntington\u2019s disease",
      "volume": "56",
      "author": "Seo",
      "year": "2004",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C25",
      "doi-asserted-by": "crossref",
      "first-page": "679",
      "DOI": "10.1093/hmg/ddi064",
      "article-title": "Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation",
      "volume": "14",
      "author": "Bowman",
      "year": "2005",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C26",
      "doi-asserted-by": "crossref",
      "first-page": "33",
      "DOI": "10.1093/hmg/ddi423",
      "article-title": "Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington\u2019s disease mice: exclusion of proteasome activator REGgamma as a therapeutic target",
      "volume": "15",
      "author": "Bett",
      "year": "2006",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C27",
      "doi-asserted-by": "crossref",
      "first-page": "109",
      "DOI": "10.1083/jcb.200306038",
      "article-title": "Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity",
      "volume": "163",
      "author": "Zhou",
      "year": "2003",
      "journal-title": "J. Cell Biol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C28",
      "doi-asserted-by": "crossref",
      "first-page": "13935",
      "DOI": "10.1074/jbc.M107706200",
      "article-title": "Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival",
      "volume": "277",
      "author": "Ding",
      "year": "2002",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C29",
      "doi-asserted-by": "crossref",
      "first-page": "11653",
      "DOI": "10.1523/JNEUROSCI.23-37-11653.2003",
      "article-title": "Neuronal induction of the immunoproteasome in Huntington\u2019s disease",
      "volume": "23",
      "author": "Diaz-Hernandez",
      "year": "2003",
      "journal-title": "J. Neurosci."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C30",
      "doi-asserted-by": "crossref",
      "first-page": "843",
      "DOI": "10.1016/S0896-6273(02)00834-6",
      "article-title": "Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy",
      "volume": "35",
      "author": "Katsuno",
      "year": "2002",
      "journal-title": "Neuron"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C31",
      "doi-asserted-by": "crossref",
      "first-page": "897",
      "DOI": "10.1038/nbt851",
      "article-title": "A transgenic mouse model of the ubiquitin/proteasome system",
      "volume": "21",
      "author": "Lindsten",
      "year": "2003",
      "journal-title": "Nat. Biotechnol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C32",
      "doi-asserted-by": "crossref",
      "first-page": "538",
      "DOI": "10.1038/75406",
      "article-title": "Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells",
      "volume": "18",
      "author": "Dantuma",
      "year": "2000",
      "journal-title": "Nat. Biotechnol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C33",
      "first-page": "705",
      "article-title": "Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells",
      "volume": "10",
      "author": "Whitesell",
      "year": "1996",
      "journal-title": "Mol. Endocrinol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C34",
      "doi-asserted-by": "crossref",
      "first-page": "22796",
      "DOI": "10.1074/jbc.271.37.22796",
      "article-title": "Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin",
      "volume": "271",
      "author": "Mimnaugh",
      "year": "1996",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C35",
      "doi-asserted-by": "crossref",
      "first-page": "3256",
      "DOI": "10.1158/0008-5472.CAN-03-3531",
      "article-title": "Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein",
      "volume": "64",
      "author": "Bonvini",
      "year": "2004",
      "journal-title": "Cancer Res."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C36",
      "doi-asserted-by": "crossref",
      "first-page": "2203",
      "DOI": "10.1523/JNEUROSCI.23-06-02203.2003",
      "article-title": "Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein",
      "volume": "23",
      "author": "Adachi",
      "year": "2003",
      "journal-title": "J. Neurosci."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C37",
      "doi-asserted-by": "crossref",
      "first-page": "587",
      "DOI": "10.1016/j.tins.2007.08.005",
      "article-title": "The ubiquitin-proteasome pathway in health and disease of the nervous system",
      "volume": "30",
      "author": "Hegde",
      "year": "2007",
      "journal-title": "Trends Neurosci."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C38",
      "doi-asserted-by": "crossref",
      "first-page": "2898",
      "DOI": "10.1073/pnas.97.6.2898",
      "article-title": "Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington\u2019s disease",
      "volume": "97",
      "author": "Wyttenbach",
      "year": "2000",
      "journal-title": "Proc. Natl Acad. Sci. USA"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C39",
      "doi-asserted-by": "crossref",
      "first-page": "537",
      "DOI": "10.1016/S0092-8674(00)80513-9",
      "article-title": "Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation",
      "volume": "90",
      "author": "Davies",
      "year": "1997",
      "journal-title": "Cell"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C40",
      "doi-asserted-by": "crossref",
      "first-page": "1990",
      "DOI": "10.1126/science.277.5334.1990",
      "article-title": "Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain",
      "volume": "277",
      "author": "DiFiglia",
      "year": "1997",
      "journal-title": "Science"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C41",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "DOI": "10.1016/S0092-8674(00)80623-6",
      "article-title": "Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease",
      "volume": "101",
      "author": "Yamamoto",
      "year": "2000",
      "journal-title": "Cell"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C42",
      "doi-asserted-by": "crossref",
      "first-page": "8853",
      "DOI": "10.1523/JNEUROSCI.2978-04.2004",
      "article-title": "Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice",
      "volume": "24",
      "author": "Zu",
      "year": "2004",
      "journal-title": "J. Neurosci."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C43",
      "doi-asserted-by": "crossref",
      "first-page": "294",
      "DOI": "10.1038/77046",
      "article-title": "Gene-expression profile of the ageing brain in mice",
      "volume": "25",
      "author": "Lee",
      "year": "2000",
      "journal-title": "Nat. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C44",
      "doi-asserted-by": "crossref",
      "first-page": "149",
      "DOI": "10.1016/S0306-4522(00)00067-1",
      "article-title": "Decreased levels of proteasome activity and proteasome expression in aging spinal cord",
      "volume": "98",
      "author": "Keller",
      "year": "2000",
      "journal-title": "Neuroscience"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C45",
      "doi-asserted-by": "crossref",
      "first-page": "407",
      "DOI": "10.1038/nature01913",
      "article-title": "A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors",
      "volume": "425",
      "author": "Kamal",
      "year": "2003",
      "journal-title": "Nature"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C46",
      "doi-asserted-by": "crossref",
      "first-page": "291",
      "DOI": "10.1007/s002800000242",
      "article-title": "Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1",
      "volume": "47",
      "author": "Egorin",
      "year": "2001",
      "journal-title": "Cancer Chemother. Pharmacol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C47",
      "first-page": "308",
      "article-title": "Comparison of geldanamycin (NSC-122750) and 17-allylaminogeldanamycin (NSC-330507D) toxicity in rats",
      "volume": "38",
      "author": "Page",
      "year": "1997",
      "journal-title": "Proc. Am. Assoc. Cancer Res."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C48",
      "doi-asserted-by": "crossref",
      "first-page": "305",
      "DOI": "10.1007/BF00689048",
      "article-title": "Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent",
      "volume": "36",
      "author": "Supko",
      "year": "1995",
      "journal-title": "Cancer Chemother. Pharmacol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C49",
      "doi-asserted-by": "crossref",
      "first-page": "2261",
      "DOI": "10.1158/1078-0432.CCR-06-2468",
      "article-title": "Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity\u2014pharmacodynamic drug-drug interaction modeling",
      "volume": "13",
      "author": "Wetzler",
      "year": "2007",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C50",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "DOI": "10.1007/s00280-004-0939-2",
      "article-title": "In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative",
      "volume": "56",
      "author": "Hollingshead",
      "year": "2005",
      "journal-title": "Cancer Chemother. Pharmacol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C51",
      "doi-asserted-by": "crossref",
      "first-page": "500",
      "DOI": "10.3816/CLM.2006.n.034",
      "article-title": "17-dimethylaminoethylamino-17-demethoxygeldanamycin in patients with advanced-stage solid tumors and lymphoma: a phase I study",
      "volume": "6",
      "author": "Shadad",
      "year": "2006",
      "journal-title": "Clin. Lymphoma Myeloma"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C52",
      "doi-asserted-by": "crossref",
      "first-page": "34",
      "DOI": "10.1002/pbc.21508",
      "article-title": "Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program",
      "volume": "51",
      "author": "Smith",
      "year": "2008",
      "journal-title": "Pediatr. Blood Cancer"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C53",
      "first-page": "2385",
      "article-title": "Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations",
      "volume": "58",
      "author": "Egorin",
      "year": "1998",
      "journal-title": "Cancer Res."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C54",
      "doi-asserted-by": "crossref",
      "first-page": "1421",
      "DOI": "10.1007/s00109-007-0251-9",
      "article-title": "Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response",
      "volume": "85",
      "author": "Zhang",
      "year": "2007",
      "journal-title": "J. Mol. Med."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C55",
      "doi-asserted-by": "crossref",
      "first-page": "1307",
      "DOI": "10.1093/hmg/10.12.1307",
      "article-title": "Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington\u2019s disease",
      "volume": "10",
      "author": "Sittler",
      "year": "2001",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C56",
      "doi-asserted-by": "crossref",
      "first-page": "16801",
      "DOI": "10.1073/pnas.0506249102",
      "article-title": "Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease",
      "volume": "102",
      "author": "Katsuno",
      "year": "2005",
      "journal-title": "Proc. Natl Acad. Sci. USA"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C57",
      "doi-asserted-by": "crossref",
      "first-page": "515",
      "DOI": "10.1093/hmg/11.5.515",
      "article-title": "Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy",
      "volume": "11",
      "author": "Bailey",
      "year": "2002",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C58",
      "doi-asserted-by": "crossref",
      "first-page": "26714",
      "DOI": "10.1074/jbc.M601603200",
      "article-title": "CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation",
      "volume": "281",
      "author": "Al-Ramahi",
      "year": "2006",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C59",
      "doi-asserted-by": "crossref",
      "first-page": "5115",
      "DOI": "10.1523/JNEUROSCI.1242-07.2007",
      "article-title": "CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model",
      "volume": "27",
      "author": "Adachi",
      "year": "2007",
      "journal-title": "J. Neurosci."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C60",
      "doi-asserted-by": "crossref",
      "first-page": "648",
      "DOI": "10.1172/JCI29715",
      "article-title": "The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins",
      "volume": "117",
      "author": "Dickey",
      "year": "2007",
      "journal-title": "J. Clin. Invest."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C61",
      "doi-asserted-by": "crossref",
      "first-page": "1185",
      "DOI": "10.1038/nm1102-1185",
      "article-title": "Pharmacological prevention of Parkinson disease in Drosophila",
      "volume": "8",
      "author": "Auluck",
      "year": "2002",
      "journal-title": "Nat. Med."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C62",
      "doi-asserted-by": "crossref",
      "first-page": "355",
      "DOI": "10.1046/j.1471-4159.2002.00835.x",
      "article-title": "Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia",
      "volume": "81",
      "author": "Lu",
      "year": "2002",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C63",
      "doi-asserted-by": "crossref",
      "first-page": "461",
      "DOI": "10.1002/jnr.10139",
      "article-title": "Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis",
      "volume": "67",
      "author": "Murphy",
      "year": "2002",
      "journal-title": "J. Neurosci. Res."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C64",
      "doi-asserted-by": "crossref",
      "first-page": "768",
      "DOI": "10.1038/nm878",
      "article-title": "Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy",
      "volume": "9",
      "author": "Katsuno",
      "year": "2003",
      "journal-title": "Nat. Med."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C65",
      "doi-asserted-by": "crossref",
      "first-page": "4524",
      "DOI": "10.1038/sj.emboj.7601338",
      "article-title": "A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes",
      "volume": "25",
      "author": "Hamazaki",
      "year": "2006",
      "journal-title": "EMBO J."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C66",
      "doi-asserted-by": "crossref",
      "first-page": "1133",
      "DOI": "10.1093/embo-reports/kve246",
      "article-title": "CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein",
      "volume": "2",
      "author": "Murata",
      "year": "2001",
      "journal-title": "EMBO Rep."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C67",
      "doi-asserted-by": "crossref",
      "first-page": "1183",
      "DOI": "10.1093/hmg/ddh131",
      "article-title": "Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy",
      "volume": "13",
      "author": "Minamiyama",
      "year": "2004",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C68",
      "doi-asserted-by": "crossref",
      "first-page": "1039",
      "DOI": "10.1093/hmg/10.10.1039",
      "article-title": "Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death",
      "volume": "10",
      "author": "Adachi",
      "year": "2001",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C69",
      "doi-asserted-by": "crossref",
      "first-page": "977",
      "DOI": "10.1016/j.molcel.2006.11.015",
      "article-title": "Cooperation of multiple chaperones required for the assembly of mammalian 20S proteasomes",
      "volume": "24",
      "author": "Hirano",
      "year": "2006",
      "journal-title": "Mol. Cell"
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C70",
      "doi-asserted-by": "crossref",
      "first-page": "6629",
      "DOI": "10.1128/MCB.00509-07",
      "article-title": "Rpn10-mediated degradation of ubiquitinated proteins is essential for mouse development",
      "volume": "27",
      "author": "Hamazaki",
      "year": "2007",
      "journal-title": "Mol. Cell. Biol."
    },
    {
      "key": "key\n\t\t\t\t20170522132258_DDN419C71",
      "doi-asserted-by": "crossref",
      "first-page": "490",
      "DOI": "10.1016/S0076-6879(05)99034-4",
      "article-title": "Monitoring of ubiquitin-dependent proteolysis with green fluorescent protein substrates",
      "volume": "399",
      "author": "Menendez-Benito",
      "year": "2005",
      "journal-title": "Methods Enzymol."
    }
  ],
  "container-title": "Human Molecular Genetics",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://academic.oup.com/hmg/article-pdf/18/5/898/17248588/ddn419.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        15
      ]
    ],
    "date-time": "2019-05-15T23:41:11Z",
    "timestamp": 1557963671000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://academic.oup.com/hmg/article-lookup/doi/10.1093/hmg/ddn419"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2008,
        12,
        9
      ]
    ]
  },
  "references-count": 71,
  "journal-issue": {
    "issue": "5",
    "published-online": {
      "date-parts": [
        [
          2008,
          12,
          9
        ]
      ]
    },
    "published-print": {
      "date-parts": [
        [
          2009,
          3,
          1
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1093/hmg/ddn419",
  "relation": {},
  "ISSN": [
    "1460-2083",
    "0964-6906"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        2008,
        12,
        9
      ]
    ]
  }
}